Pharmaceutical / Drug Definition :
Suppresses calcium transport into vascular smooth muscle cells. This suppression inhibits vasoconstriction and dilates coronary arteries, improving myocardial oxygen uptake.
Nisoldipine (Nisoldipine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Nisoldipine (Nisoldipine Suppliers)
- Processors Nisoldipine
- Repackers Nisoldipine
- Relabelers Nisoldipine
- Exporters Nisoldipine
- Importers Nisoldipine
For more information about Nisoldipine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.